4 completed, 1 terminated. 2 Phase 3, 1 Phase 1, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Terminated 1 |
| Phase 4 | 1 | Completed 1 |
Follow LIXISENATIDE AVE0010: new trials by email Literature Review of LIXISENATIDE AVE0010 trials Research Report on LIXISENATIDE AVE0010
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Lixisenatide on Postprandial Lipid Profile in Obese Type 2 Diabetic Patients LIXISENATIDE AVE0010, metformin - Type II Diabetes Mellitus | Phase 2 | Terminated | Sanofi | 2 | 2015-04-01 | 2017-01-30 |
| Effect of Lixisenatide on Postprandial Plasma Glucose Compared to Sitagliptin in Combination With Insulin Glargine LIXISENATIDE AVE0010, Sitagliptin, Insulin glargine HOE901 - Type 2 Diabetes Mellitus | Phase 4 | Completed | Sanofi | 136 | 2014-08-01 | 2016-10-05 |
| Safety And Tolerability Of Lixisenatide In Monotherapy In Patients With Type 2 Diabetes lixisenatide AVE0010 - Type 2 Diabetes Mellitus | Phase 3 | Completed | Sanofi | 361 | 2013-11-01 | 2015-04-09 |
| Safety and Tolerability of Lixisenatide in Combination With Oral Anti-Diabetic Treatment in Patients With Type 2 Diabetes lixisenatide AVE0010, biguanide, TZD - Type 2 Diabetes Mellitus | Phase 3 | Completed | Sanofi | 294 | 2013-09-01 | 2015-08-04 |
| Relative Bioavailability and Activity of Different Formulations of Insulin Glargine and Lixisenatide in Patients With Diabetes Mellitus Type 1 Insulin glargine HOE901, Lixisenatide AVE0010 - Type 1 Diabetes Mellitus | Phase 1 | Completed | Sanofi | 22 | 2010-06-01 | 2011-03-02 |
Diabetes Mellitus, Type 2 (4) · Diabetes Mellitus, Type 1 (1)
Sanofi (5)
Japan (3) · Germany (1)